デフォルト表紙
市場調査レポート
商品コード
1426442

ゴーシェ病の世界市場レポート 2024

Gaucher's Disease Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
ゴーシェ病の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

ゴーシェ病の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.5%の年間複合成長率(CAGR)で20億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、次世代治療法の出現、世界の患者登録の拡大、治療へのアクセスの強化、個別化医療戦略、希少疾患に対する規制の支援に関連している可能性があります。予測期間中に予測される主な動向には、治療モニタリングにおける技術の進歩、国際的な調査協力、経口治療の進歩、新生児スクリーニングプログラムの拡大、患者アクセスを促進する世界の取り組みが含まれます。

ゴーシェ病市場は、遺伝子異常の有病率の増加により成長すると予想されています。遺伝子異常には、人のDNA配列の突然変異が関与し、異常な特徴や機能が生じます。 ゴーシェ病は常染色体劣性遺伝パターンを持ち、この状態を発症するには、変異したGBA遺伝子のコピーを2つ継承する必要があります。 ゴーシェ病の影響を受けると十分な酵素の生成が不足し、脾臓や肝臓などの臓器に脂質が蓄積します。注目すべきことに、2021年5月のMedlinePlusの報告では、毎年アメリカ人の約20万人に1人が症候群Aを特定し、約10万人の子供が症候群Bに苦しんでいることが強調されています。さらに、2020年には世界で推定12,000人がC症候群により死亡し、米国ではおよそ1%の人が一生の間にD障害を発症しており、このような遺伝子異常の有病率の増加は、ゴーシェ病市場の成長を促進する要因となっています。

ゴーシェ病市場の成長は、臨床試験数の増加によって促進されると予想されます。人間の参加者が参加する臨床試験では、新しい治療法、介入、または薬剤の安全性と有効性が評価されます。 ゴーシェ病での臨床試験の増加は、治療の進歩、疾患の理解の向上、診断とスクリーニングの改善、および個別化医療の発展の可能性につながる可能性があります。 2023年 5月のXtalksによると、452,604件の臨床研究が登録されており、64,838人が積極的に参加者を求めています。これは、2021年の登録試験数365,000件から大幅に増加し、ゴーシェ病市場の成長に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のゴーシェ病市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • ゴーシェ病 1型
  • ゴーシェ病 2型
  • ゴーシェ病 3型
  • その他
  • 世界のゴーシェ病市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 身体検査
  • 血液検査
  • 画像検査
  • 妊娠前スクリーニングと出生前検査
  • その他
  • 世界のゴーシェ病市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 酵素補充療法
  • 基質減少療法
  • 世界のゴーシェ病市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界のゴーシェ病市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • 在宅ケア
  • その他

第7章 地域および国の分析

  • 世界のゴーシェ病市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のゴーシェ病市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ゴーシェ病市場の競合情勢
  • ゴーシェ病市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Merck and Co. Inc.
    • Novartis AG
    • Sanofi SA

第31章 その他の大手および革新的な企業

  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Moderna Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • BioMarin Pharmaceutical Inc.
  • CHIESI Farmaceutici SPA
  • IntraBio Inc.
  • REGENXBIO Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Ultragenyx Pharmaceutical Inc.
  • Amicus Therapeutics Inc.
  • Pharming Group NV
  • Idorsia Pharmaceuticals Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13454

Gaucher's disease, a rare genetic disorder, disrupts the metabolism of a specific type of fat known as glucocerebroside. The disorder arises from the accumulation of a fatty substance called glucocerebroside within certain cells, particularly in the spleen, liver, bone marrow, and sometimes in the brain.

The primary categories of Gaucher's disease encompass Gaucher disease type 1, Gaucher disease type 2, Gaucher disease type 3, and others. Gaucher disease type 1, the most prevalent form, is distinguished by a deficiency of the enzyme glucocerebrosidase. The diverse diagnostic methods include physical examinations, blood tests, imaging tests, preconception screening, prenatal testing, and others. Treatment options involve enzyme replacement therapy and substrate reduction therapy, which can be administered through oral, parenteral, and various other routes by end users such as hospitals, specialty clinics, homecare, and others.

The Gaucher's disease market research report is one of a series of new reports from The Business Research Company that provides Gaucher's disease market statistics, including the Gaucher's disease industry global market size, regional shares, competitors with Gaucher's disease market share, detailed Gaucher's disease market segments, market trends and opportunities, and any further data you may need to thrive in the Gaucher's disease industry. This Gaucher's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gaucher's disease market size has grown strongly in recent years. It will grow from $1.58 billion in 2023 to $1.68 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be ascribed to the development of enzyme replacement therapy (ERT), heightened awareness of the disease, advancements in genetic research and diagnosis, initiatives in patient advocacy, and government incentives targeting rare diseases.

The gaucher's disease market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period can be linked to the emergence of next-generation therapies, the expansion of global patient registries, enhanced access to treatment, personalized medicine strategies, and regulatory backing for rare diseases. Key trends projected in the forecast period encompass technological advancements in treatment monitoring, international research collaborations, progress in oral therapeutics, the expansion of newborn screening programs, and global initiatives fostering patient access.

The gaucher's disease market is anticipated to experience growth due to the increasing prevalence of genetic abnormalities. Genetic abnormalities involve mutations in a person's DNA sequence, leading to abnormal features or functions. Gaucher's disease, with an autosomal recessive inheritance pattern, requires individuals to inherit two mutated GBA gene copies to develop the condition. Those affected by Gaucher's disease lack sufficient enzyme production, resulting in lipid buildup in organs such as the spleen and liver. Notably, reports from MedlinePlus in May 2021 highlighted the identification of syndrome A in about 1 in 200,000 Americans annually, with around 100,000 children suffering from syndrome B. Additionally, an estimated 12,000 global deaths occurred from syndrome C in 2020, and approximately 1% of individuals in the United States developed disorder D during their lifetimes. This increasing prevalence of genetic abnormalities is a driving factor in the growth of the Gaucher's disease market.

The growth of the Gaucher's disease market is expected to be fueled by the rising number of clinical trials. Clinical trials, involving human participants, evaluate the safety and efficacy of new medical treatments, interventions, or drugs. Increased clinical trials in Gaucher's disease can lead to advancements in treatment, better disease understanding, improved diagnosis and screening, and the potential development of personalized medicine. According to Xtalks in May 2023, there are 452,604 registered clinical studies, with 64,838 actively seeking participants. This marks a substantial increase from the 365,000 registered trials in 2021, contributing significantly to the growth of the Gaucher's disease market.

Challenges to the growth of the Gaucher's disease market are anticipated due to the lack of imiglucerase supply. Imiglucerase is a crucial medication for Gaucher disease, replacing the deficient enzyme. The scarcity of imiglucerase, as reported by the National Library of Medicine in August 2022, resulted in adverse clinical effects for Italian patients with Gaucher type I. This shortage poses a hindrance to the growth of the Gaucher disease market.

Major companies in the Gaucher's disease market are adopting innovative technologies such as next-generation sequencing (NGS) to enhance patient care. NGS, a high-throughput sequencing technology, enables rapid and cost-effective DNA and RNA sequencing. For instance, Eurofins Genomics LLC launched a whole plasmid sequencing service utilizing advanced Gen3 NGS technology, offering same-day results with up to 99% single-base accuracy. This service, accommodating DNA constructs from 2.5 to 300 kb, combines the accuracy and quick turnaround of Sanger sequencing with NGS's comprehensive analysis capabilities, providing a cost-effective and time-efficient solution for genetic analysis.

In January 2021, Eli Lilly and Company, a US-based pharmaceutical company, acquired Prevail Therapeutics Inc. for $1.04 billion. This acquisition aims to expand Lilly's drug discovery and development approach, launching a gene therapy program supported by Prevail's clinical-stage and preclinical neuroscience assets. Prevail Therapeutics Inc., a gene therapy company, focuses on developing treatments for various Gaucher disease types, including neuronopathic Gaucher disease and Type 1 Gaucher disease.

Major companies operating in the gaucher's disease market report are Pfizer Inc., Johnson & Johnson, Merck and Co. Inc., Novartis AG, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Moderna Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, BioMarin Pharmaceutical Inc., CHIESI Farmaceutici SPA, IntraBio Inc., REGENXBIO Inc., JCR Pharmaceuticals Co. Ltd., Ultragenyx Pharmaceutical Inc., Amicus Therapeutics Inc., Pharming Group N.V., Idorsia Pharmaceuticals Ltd., Centogene N.V., Protalix BioTherapeutics, AVROBIO Inc., Resverlogix Corp., GenSight Biologics S.A., ISU Abxis Co. Ltd., SIRION BIOTECH GmbH, Greenovation Biotech GmbH, Orphazyme A/S

North America was the largest region in the Gaucher's disease market in 2023. Europe is expected to be the fastest growing region in the forecast period. The regions covered in the gaucher's disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gaucher's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gaucher's disease market includes revenues earned by entities by providing services such as genetic counseling, patient education and support, research and clinical trials, and pain management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The gaucher's disease market consists of sales of bone health supplements, medical equipment, and diagnostic testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gaucher's Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on Gaucher's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for Gaucher's disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Gaucher's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Gaucher Disease Type 1; Gaucher Disease Type 2; Gaucher Disease Type 3; Other Types
  • 2) By Diagnosis: Physical Exam; Blood Tests; Imaging Tests; Preconception Screening and Prenatal Testing; Other Diagnoses
  • 3) By Therapy: Enzyme Replacement Therapy; Substrate Reduction Therapy
  • 4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 5) By End User: Hospitals; Specialty Clinics; Homecare; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck and Co. Inc.; Novartis AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gaucher's Disease Market Characteristics

3. Gaucher's Disease Market Trends And Strategies

4. Gaucher's Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gaucher's Disease Market Size and Growth

  • 5.1. Global Gaucher's Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gaucher's Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gaucher's Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gaucher's Disease Market Segmentation

  • 6.1. Global Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Other Types
  • 6.2. Global Gaucher's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Physical Exam
  • Blood Tests
  • Imaging Tests
  • Preconception Screening and Prenatal Testing
  • Other Diagnoses
  • 6.3. Global Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzyme Replacement Therapy
  • Substrate Reduction Therapy
  • 6.4. Global Gaucher's Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.5. Global Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End Users

7. Gaucher's Disease Market Regional And Country Analysis

  • 7.1. Global Gaucher's Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gaucher's Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gaucher's Disease Market

  • 8.1. Asia-Pacific Gaucher's Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gaucher's Disease Market

  • 9.1. China Gaucher's Disease Market Overview
  • 9.2. China Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gaucher's Disease Market

  • 10.1. India Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gaucher's Disease Market

  • 11.1. Japan Gaucher's Disease Market Overview
  • 11.2. Japan Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gaucher's Disease Market

  • 12.1. Australia Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gaucher's Disease Market

  • 13.1. Indonesia Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gaucher's Disease Market

  • 14.1. South Korea Gaucher's Disease Market Overview
  • 14.2. South Korea Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gaucher's Disease Market

  • 15.1. Western Europe Gaucher's Disease Market Overview
  • 15.2. Western Europe Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gaucher's Disease Market

  • 16.1. UK Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gaucher's Disease Market

  • 17.1. Germany Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gaucher's Disease Market

  • 18.5. France Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gaucher's Disease Market

  • 19.9. Italy Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gaucher's Disease Market

  • 20.13. Spain Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gaucher's Disease Market

  • 21.1. Eastern Europe Gaucher's Disease Market Overview
  • 21.2. Eastern Europe Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gaucher's Disease Market

  • 22.1. Russia Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gaucher's Disease Market

  • 23.1. North America Gaucher's Disease Market Overview
  • 23.2. North America Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gaucher's Disease Market

  • 24.1. USA Gaucher's Disease Market Overview
  • 24.2. USA Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gaucher's Disease Market

  • 25.1. Canada Gaucher's Disease Market Overview
  • 25.2. Canada Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gaucher's Disease Market

  • 26.1. South America Gaucher's Disease Market Overview
  • 26.2. South America Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gaucher's Disease Market

  • 27.1. Brazil Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gaucher's Disease Market

  • 28.1. Middle East Gaucher's Disease Market Overview
  • 28.2. Middle East Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gaucher's Disease Market

  • 29.1. Africa Gaucher's Disease Market Overview
  • 29.2. Africa Gaucher's Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gaucher's Disease Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gaucher's Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gaucher's Disease Market Competitive Landscape And Company Profiles

  • 30.1. Gaucher's Disease Market Competitive Landscape
  • 30.2. Gaucher's Disease Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck and Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gaucher's Disease Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. GlaxoSmithKline plc
  • 31.3. Takeda Pharmaceutical Company Limited
  • 31.4. Moderna Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Boehringer Ingelheim International GmbH
  • 31.7. BioMarin Pharmaceutical Inc.
  • 31.8. CHIESI Farmaceutici SPA
  • 31.9. IntraBio Inc.
  • 31.10. REGENXBIO Inc.
  • 31.11. JCR Pharmaceuticals Co. Ltd.
  • 31.12. Ultragenyx Pharmaceutical Inc.
  • 31.13. Amicus Therapeutics Inc.
  • 31.14. Pharming Group N.V.
  • 31.15. Idorsia Pharmaceuticals Ltd.

32. Global Gaucher's Disease Market Competitive Benchmarking

33. Global Gaucher's Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gaucher's Disease Market

35. Gaucher's Disease Market Future Outlook and Potential Analysis

  • 35.1 Gaucher's Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gaucher's Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gaucher's Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer